calendar
4,883 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
4,883 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
Sponsor: Washington State University. Phase: EARLY_PHASE1. Conditions: Interaction
Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE2. Conditions: Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Unresectable Dedifferentiated Liposarcoma
Sponsor: University Hospital Tuebingen. Phase: . Conditions: Congenital Heart Disease (CHD)
Sponsor: Weill Medical College of Cornell University. Phase: PHASE4. Conditions: Meningioma
Sponsor: NYU Langone Health. Phase: NA. Conditions: Alopecia
Sponsor: Zimmer Biomet. Phase: . Conditions: Osteotomy, Trochanteric Fractures, Sub-trochanteric Fractures, Femoral Shaft Fracture
Sponsor: Gloucestershire Hospitals NHS Foundation Trust. Phase: . Conditions: Cardio Vascular Disease
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Adult Patients With Lesions on Fingers or Toes
Sponsor: AdventHealth Translational Research Institute. Phase: . Conditions: Insulin Resistance
Sponsor: Cumhuriyet University. Phase: NA. Conditions: Childbirth, Duration of Labor, Labor Pains, Pushing During Childbirth, Fatigue During Childbirth
Sponsor: Mahidol University. Phase: NA. Conditions: Critically Ill Patients
Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Hypertension, Interstitial Lung Disease
Sponsor: Laval University. Phase: NA. Conditions: Insomnia Disorder
Sponsor: National Eye Institute (NEI). Phase: . Conditions: Age-Related Macular Degeneration
Sponsor: Daiichi Sankyo. Phase: PHASE2. Conditions: Urothelial Cancer, Bladder Cancer
Sponsor: CoreAalst BV. Phase: . Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)
Sponsor: Chestnut Health Systems. Phase: NA. Conditions: Polysubstance Drug Use (Indiscriminate Drug Use)
Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Aortic Stenosis
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Colorectal Cancer
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Multiple Myeloma
Sponsor: Fondazione Don Carlo Gnocchi Onlus. Phase: NA. Conditions: Critical Illness, Post Intensive Care Syndrome (PICS), Cardiopathy
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: DOCK8 Deficiency
Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Mental Health, Depression and Burden in Caregivers, Anxiety Depression, Stress, Caregiver Anxiety, Parent of Child With Chronic Life-threatening Illness
Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma
Sponsor: University of Milano Bicocca. Phase: . Conditions: Mechanical Ventilation, Acute Brain Injury
Sponsor: University Hospital, Ghent. Phase: . Conditions: Cardiac Arrest (CA), Out-of-hospital Cardiac Arrest (OHCA), Resuscitated Sudden Cardiac Death
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.. Phase: . Conditions: Tetanus
Sponsor: ENBIOSIS BIOTECHNOLOGIES. Phase: NA. Conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Colitis
Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd. Phase: PHASE1. Conditions: Acute Pain
Sponsor: Zhujiang Hospital. Phase: . Conditions: Metabolic Dysfunction-associated Fatty Liver Disease
Sponsor: Janssen Sciences Ireland UC. Phase: PHASE3. Conditions: HIV Infections, HIV-1
Sponsor: Kevin Hill. Phase: PHASE3. Conditions: Congenital Heart Disease in Children, Inflammatory Response
Sponsor: RenJi Hospital. Phase: . Conditions: Advanced Breast Cancer
Sponsor: Kirsehir Ahi Evran Universitesi. Phase: . Conditions: Near-Infrared Spectroscopy
Sponsor: Rinri Therapeutics. Phase: PHASE1. Conditions: Sensorineural Hearing Loss, Presbyacusis, Auditory Neuropathy
Sponsor: Blueprint Medicines Corporation. Phase: . Conditions: Indolent Systemic Mastocytosis
Sponsor: BioArctic AB. Phase: PHASE2. Conditions: Parkinson Disease, Multiple System Atrophy
Sponsor: King's College London. Phase: NA. Conditions: Autism, Autism in Children
Sponsor: Hospital Universitari de Bellvitge. Phase: . Conditions: Intubated ICU Patients, Ventilator Associated Pneumonia ( VAP), Immunoparalysis
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Parathyroid Cancer, Primary Hyperparathyroidism, Pseudohypoparathyroidism, Inheritable Bone Diseases, Multiple Endocrine Neoplasia, Type 1
Sponsor: Riphah International University. Phase: NA. Conditions: Diabetic Neuropathies
Sponsor: ACADIA Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Alzheimer's Disease Psychosis
Sponsor: Anasonic. Phase: NA. Conditions: Chronic Kidney Disease
Sponsor: Karolinska Institutet. Phase: . Conditions: Anesthesia Complication, Tracheostomy Complications, Children Receiving General Anesthesia
Sponsor: University of Wuerzburg. Phase: . Conditions: Adrenocortical Carcinoma, Cushing's Syndrome
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Carcinoma, Hepatocellular
Sponsor: University Hospital, Lille. Phase: PHASE2. Conditions: Crohn's Ileocolitis
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Healthy Volunteer
Sponsor: Universidad Europea de Madrid. Phase: NA. Conditions: Muscle Tone, Healthy Adult
Sponsor: Shaheed Mohtarma Benazir Bhutto Institue of Trauma. Phase: NA. Conditions: HEMODYNAMIC RESPONSETO LYRANGOSCOPY AND ENDOTRACHEAL INTUBATION